AL
PGNX

Airain Ltd’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Airain Ltd’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-31,866
Closed -$301K – 1124
2017
Q1 		$301K Buy
+31,866
New +$318K 0.01% 617
2015
Q4 		– Sell
-37,114
Closed -$212K – 1136
2015
Q3 		$212K Buy
+37,114
New +$285K 0.01% 696
2015
Q2 		– Sell
-79,863
Closed -$478K – 1169
2015
Q1 		$478K Buy
79,863
+59,420
+291% +$374K 0.03% 506
2014
Q4 		$155K Buy
+20,443
New +$122K 0.01% 623
2014
Q1 		– Sell
-12,296
Closed -$66K – 912
2013
Q4 		$66K Sell
12,296
-11,434
-48% -$50.3K 0.01% 534
2013
Q3 		$119K Buy
+23,730
New +$129K 0.02% 430

Other funds holding PGNX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
PFC
Phocas Financial Corp Alameda, California $637M AUM 39.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Airain Ltd's PGNX Position: Q2 2017 in Review

Airain Ltd sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2017, closing a stake of 31,866 shares — an estimated $301K sold.

Airain Ltd first reported a position in PGNX in Q3 2013 and held it in 6 quarters. The position peaked at $478K in Q1 2015. 152 funds tracked by Wall St. Rank hold PGNX as of Q2 2017.

  • Airain Ltd reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2017 after selling out during the quarter.
  • Airain Ltd sold 31,866 Progenics Pharmaceuticals Inc shares in Q2 2017, an estimated $301K.
  • Airain Ltd first reported a position in Progenics Pharmaceuticals Inc in Q3 2013 and held it in 6 quarters.
  • Airain Ltd's Progenics Pharmaceuticals Inc position peaked at $478K in Q1 2015.
  • 152 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.